 | • レポートコード：MRC2Q12-11140 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：食品＆飲料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、生合成ヒト乳オリゴ糖（HMO）の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に生合成ヒト乳オリゴ糖（HMO）のグローバル市場のxxx％を占める「2'-FL・3-FL」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「幼児用フォミュラー」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 生合成ヒト乳オリゴ糖（HMO）の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの生合成ヒト乳オリゴ糖（HMO）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 生合成ヒト乳オリゴ糖（HMO）のグローバル主要プレイヤーには、DSM (Glycom)、Dupont (Inbiose)、BASF (Glycosyn)、Chr. Hansen (Jennewein)、Abbott、FrieslandCampinaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 生合成ヒト乳オリゴ糖（HMO）市場は、種類と用途によって区分されます。世界の生合成ヒト乳オリゴ糖（HMO）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 2'-FL・3-FL、LNT・LNnT,etc. 【用途別セグメント】 幼児用フォミュラー、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 生合成ヒト乳オリゴ糖（HMO）製品概要 - 種類別市場（2'-FL・3-FL、LNT・LNnT,etc.） - 用途別市場（幼児用フォミュラー、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の生合成ヒト乳オリゴ糖（HMO）販売量予測2017-2028 - 世界の生合成ヒト乳オリゴ糖（HMO）売上予測2017-2028 - 生合成ヒト乳オリゴ糖（HMO）の地域別販売量 - 生合成ヒト乳オリゴ糖（HMO）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別生合成ヒト乳オリゴ糖（HMO）販売量 - 主要メーカー別生合成ヒト乳オリゴ糖（HMO）売上 - 主要メーカー別生合成ヒト乳オリゴ糖（HMO）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（2'-FL・3-FL、LNT・LNnT,etc.） - 生合成ヒト乳オリゴ糖（HMO）の種類別販売量 - 生合成ヒト乳オリゴ糖（HMO）の種類別売上 - 生合成ヒト乳オリゴ糖（HMO）の種類別価格 ・用途別市場規模（幼児用フォミュラー、その他） - 生合成ヒト乳オリゴ糖（HMO）の用途別販売量 - 生合成ヒト乳オリゴ糖（HMO）の用途別売上 - 生合成ヒト乳オリゴ糖（HMO）の用途別価格 ・北米市場 - 北米の生合成ヒト乳オリゴ糖（HMO）市場規模（種類別、用途別） - 主要国別の生合成ヒト乳オリゴ糖（HMO）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの生合成ヒト乳オリゴ糖（HMO）市場規模（種類別、用途別） - 主要国別の生合成ヒト乳オリゴ糖（HMO）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の生合成ヒト乳オリゴ糖（HMO）市場規模（種類別、用途別） - 主要国別の生合成ヒト乳オリゴ糖（HMO）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の生合成ヒト乳オリゴ糖（HMO）市場規模（種類別、用途別） - 主要国別の生合成ヒト乳オリゴ糖（HMO）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの生合成ヒト乳オリゴ糖（HMO）市場規模（種類別、用途別） - 主要国別の生合成ヒト乳オリゴ糖（HMO）市場規模（トルコ、サウジアラビア） ・企業情報 DSM (Glycom)、Dupont (Inbiose)、BASF (Glycosyn)、Chr. Hansen (Jennewein)、Abbott、FrieslandCampina ・産業チェーン及び販売チャネル分析 - 生合成ヒト乳オリゴ糖（HMO）の産業チェーン分析 - 生合成ヒト乳オリゴ糖（HMO）の原材料 - 生合成ヒト乳オリゴ糖（HMO）の生産プロセス - 生合成ヒト乳オリゴ糖（HMO）の販売及びマーケティング - 生合成ヒト乳オリゴ糖（HMO）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 生合成ヒト乳オリゴ糖（HMO）の産業動向 - 生合成ヒト乳オリゴ糖（HMO）のマーケットドライバー - 生合成ヒト乳オリゴ糖（HMO）の課題 - 生合成ヒト乳オリゴ糖（HMO）の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Biosynthetic Human Milk Oligosaccharides (HMOs) estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Biosynthetic Human Milk Oligosaccharides (HMOs) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Biosynthetic Human Milk Oligosaccharides (HMOs) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Biosynthetic Human Milk Oligosaccharides (HMOs) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Biosynthetic Human Milk Oligosaccharides (HMOs) include DSM (Glycom), Dupont (Inbiose), BASF (Glycosyn), Chr. Hansen (Jennewein), Abbott and FrieslandCampina, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biosynthetic Human Milk Oligosaccharides (HMOs) companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Biosynthetic Human Milk Oligosaccharides (HMOs) market. Further, it explains the major drivers and regional dynamics of the global Biosynthetic Human Milk Oligosaccharides (HMOs) market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
DSM (Glycom)
Dupont (Inbiose)
BASF (Glycosyn)
Chr. Hansen (Jennewein)
Abbott
FrieslandCampina
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Biosynthetic Human Milk Oligosaccharides (HMOs) Segment by Type
2′-FL & 3-FL
LNT & LNnT, etc.
Biosynthetic Human Milk Oligosaccharides (HMOs) Segment by Application
Infant Formula
Other Applications
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biosynthetic Human Milk Oligosaccharides (HMOs) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Biosynthetic Human Milk Oligosaccharides (HMOs) market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Biosynthetic Human Milk Oligosaccharides (HMOs), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosynthetic Human Milk Oligosaccharides (HMOs), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosynthetic Human Milk Oligosaccharides (HMOs) revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Biosynthetic Human Milk Oligosaccharides (HMOs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Biosynthetic Human Milk Oligosaccharides (HMOs) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including DSM (Glycom), Dupont (Inbiose), BASF (Glycosyn), Chr. Hansen (Jennewein), Abbott and FrieslandCampina, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosynthetic Human Milk Oligosaccharides (HMOs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthetic Human Milk Oligosaccharides (HMOs) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosynthetic Human Milk Oligosaccharides (HMOs) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 2′-FL & 3-FL
1.2.3 LNT & LNnT, etc.
1.3 Market by Application
1.3.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infant Formula
1.3.3 Other Applications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Perspective (2017-2028)
2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Growth Trends by Region
2.2.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Region (2017-2022)
2.2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2023-2028)
2.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Dynamics
2.3.1 Biosynthetic Human Milk Oligosaccharides (HMOs) Industry Trends
2.3.2 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers
2.3.3 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges
2.3.4 Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue
3.1.1 Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Revenue (2017-2022)
3.1.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Players (2017-2022)
3.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue
3.4 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio
3.4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2021
3.5 Biosynthetic Human Milk Oligosaccharides (HMOs) Key Players Head office and Area Served
3.6 Key Players Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service
3.7 Date of Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Type
4.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Type (2017-2022)
4.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2023-2028)
5 Biosynthetic Human Milk Oligosaccharides (HMOs) Breakdown Data by Application
5.1 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Historic Market Size by Application (2017-2022)
5.2 Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2028)
6.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type
6.2.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022)
6.2.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028)
6.2.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type (2017-2028)
6.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application
6.3.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022)
6.3.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028)
6.3.3 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application (2017-2028)
6.4 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country
6.4.1 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022)
6.4.2 North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2028)
7.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type
7.2.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022)
7.2.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028)
7.2.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type (2017-2028)
7.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application
7.3.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022)
7.3.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028)
7.3.3 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application (2017-2028)
7.4 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country
7.4.1 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022)
7.4.2 Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2028)
8.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type
8.2.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type (2017-2028)
8.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application
8.3.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application (2017-2028)
8.4 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region
8.4.1 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2028)
9.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type
9.2.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022)
9.2.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028)
9.2.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type (2017-2028)
9.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application
9.3.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022)
9.3.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028)
9.3.3 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application (2017-2028)
9.4 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country
9.4.1 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022)
9.4.2 Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (2017-2028)
10.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type
10.2.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type (2017-2028)
10.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application
10.3.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application (2017-2028)
10.4 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country
10.4.1 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 DSM (Glycom)
11.1.1 DSM (Glycom) Company Details
11.1.2 DSM (Glycom) Business Overview
11.1.3 DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.1.4 DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.1.5 DSM (Glycom) Recent Developments
11.2 Dupont (Inbiose)
11.2.1 Dupont (Inbiose) Company Details
11.2.2 Dupont (Inbiose) Business Overview
11.2.3 Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.2.4 Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.2.5 Dupont (Inbiose) Recent Developments
11.3 BASF (Glycosyn)
11.3.1 BASF (Glycosyn) Company Details
11.3.2 BASF (Glycosyn) Business Overview
11.3.3 BASF (Glycosyn) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.3.4 BASF (Glycosyn) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.3.5 BASF (Glycosyn) Recent Developments
11.4 Chr. Hansen (Jennewein)
11.4.1 Chr. Hansen (Jennewein) Company Details
11.4.2 Chr. Hansen (Jennewein) Business Overview
11.4.3 Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.4.4 Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.4.5 Chr. Hansen (Jennewein) Recent Developments
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.5.4 Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.5.5 Abbott Recent Developments
11.6 FrieslandCampina
11.6.1 FrieslandCampina Company Details
11.6.2 FrieslandCampina Business Overview
11.6.3 FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Introduction
11.6.4 FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
11.6.5 FrieslandCampina Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of 2'-FL & 3-FL
Table 3. Key Players of LNT & LNnT, etc.
Table 4. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2017-2022)
Table 8. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region (2023-2028)
Table 10. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Trends
Table 11. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Drivers
Table 12. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Challenges
Table 13. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Restraints
Table 14. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Share by Players (2017-2022)
Table 16. Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) as of 2021)
Table 17. Ranking of Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biosynthetic Human Milk Oligosaccharides (HMOs) Product Solution and Service
Table 21. Date of Enter into Biosynthetic Human Milk Oligosaccharides (HMOs) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2017-2022)
Table 25. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Market Share by Type (2023-2028)
Table 27. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Share by Application (2017-2022)
Table 29. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue Share by Application (2023-2028)
Table 31. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size by Country (2023-2028) & (US$ Million)
Table 61. DSM (Glycom) Company Details
Table 62. DSM (Glycom) Business Overview
Table 63. DSM (Glycom) Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 64. DSM (Glycom) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 65. DSM (Glycom) Recent Developments
Table 66. Dupont (Inbiose) Company Details
Table 67. Dupont (Inbiose) Business Overview
Table 68. Dupont (Inbiose) Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 69. Dupont (Inbiose) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 70. Dupont (Inbiose) Recent Developments
Table 71. BASF (Glycosyn) Company Details
Table 72. BASF (Glycosyn) Business Overview
Table 73. BASF (Glycosyn) Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 74. BASF (Glycosyn) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 75. BASF (Glycosyn) Recent Developments
Table 76. Chr. Hansen (Jennewein) Company Details
Table 77. Chr. Hansen (Jennewein) Business Overview
Table 78. Chr. Hansen (Jennewein) Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 79. Chr. Hansen (Jennewein) Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 80. Chr. Hansen (Jennewein) Recent Developments
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 84. Abbott Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 85. Abbott Recent Developments
Table 86. FrieslandCampina Company Details
Table 87. FrieslandCampina Business Overview
Table 88. FrieslandCampina Biosynthetic Human Milk Oligosaccharides (HMOs) Product
Table 89. FrieslandCampina Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022) & (US$ Million)
Table 90. FrieslandCampina Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Type: 2021 VS 2028
Figure 2. 2'-FL & 3-FL Features
Figure 3. LNT & LNnT, etc. Features
Figure 4. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Application: 2021 VS 2028
Figure 5. Infant Formula Case Studies
Figure 6. Other Applications Case Studies
Figure 7. Biosynthetic Human Milk Oligosaccharides (HMOs) Report Years Considered
Figure 8. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Region: 2021 VS 2028
Figure 11. Global Biosynthetic Human Milk Oligosaccharides (HMOs) Market Share by Players in 2021
Figure 12. Global Top Biosynthetic Human Milk Oligosaccharides (HMOs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosynthetic Human Milk Oligosaccharides (HMOs) as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Biosynthetic Human Milk Oligosaccharides (HMOs) Revenue in 2021
Figure 14. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Type (2017-2028)
Figure 16. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Application (2017-2028)
Figure 17. North America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Country (2017-2028)
Figure 18. United States Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Type (2017-2028)
Figure 22. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Application (2017-2028)
Figure 23. Europe Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Country (2017-2028)
Figure 24. Germany Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Region (2017-2028)
Figure 34. China Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Country (2017-2028)
Figure 44. Mexico Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size Share by Country (2017-2028)
Figure 50. Turkey Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Biosynthetic Human Milk Oligosaccharides (HMOs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. DSM (Glycom) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 54. Dupont (Inbiose) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 55. BASF (Glycosyn) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 56. Chr. Hansen (Jennewein) Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 57. Abbott Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 58. FrieslandCampina Revenue Growth Rate in Biosynthetic Human Milk Oligosaccharides (HMOs) Business (2017-2022)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed